|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| A61K 31/437 | (2006.01) | ||
| A61P 37/00 | (2006.01) |
| (11) | Number of the document | 3510033 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17777966.7 |
| Date of filing the European patent application | 2017-09-06 | |
| (97) | Date of publication of the European application | 2019-07-17 |
| (45) | Date of publication and mention of the grant of the patent | 2021-11-24 |
| (46) | Date of publication of the claims translation | 2022-02-25 |
| (86) | Number | PCT/IB2017/055375 |
| Date | 2017-09-06 |
| (87) | Number | WO 2018/047081 |
| Date | 2018-03-15 |
| (30) | Number | Date | Country code |
| 201662385726 P | 2016-09-09 | US |
| (72) |
ALPER, Phillip , US
DEANE, Jonathan , US
JIANG, Songchun , US
JIANG, Tao , US
KNOEPFEL, Thomas , CH
MICHELLYS, Pierre-Yves , US
MUTNICK, Daniel , US
PEI, Wei , US
SYKA, Peter , US
ZHANG, Guobao , CN
ZHANG, Yi , US
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Junginiai ir kompozicijos kaip endosominių Toll tipo receptorių inhibitoriai |
| COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF ENDOSOMAL TOLL-LIKE RECEPTORS |
| Payment date | Validity (years) | Amount | |
| 2025-08-25 | 9 | 208.00 EUR |
| 2026-09-06 |